Figure 8 - 3(d) objections by application type, over time.
Panel (a) Primary applications; Panel (b) Secondary applications. Based on 1283 applications with a first examination report. Figure 8 – 3(d) objections by application type, over time
Business Intelligence on Biologic and Small Molecule Drugs